Metraipolis › archive › dc_f8bbef59b66a
T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform — Europe PMC PMID:41601701
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41601701
- DOI
- 10.3389/fimmu.2025.1723110
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T21:21:30.092Z
- SHA-256 of the archived text
6ff7c5e91cba162655a979fa4cfb35adaadd4781ebe81829f5e32645dd9d9c59- Stable URL of this page
https://metraipolis.com/documento/dc_f8bbef59b66a
How to cite
T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform — Europe PMC PMID:41601701 — Europe PMC (en), https://europepmc.org/article/MED/41601701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8bbef59b66a (Metraipolis archive dc_f8bbef59b66a, sha256 6ff7c5e91cba162655a979fa4cfb35adaadd4781ebe81829f5e32645dd9d9c59)
BibTeX
@misc{dcf8bbef59b66a,
title = {T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform — Europe PMC PMID:41601701},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41601701},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8bbef59b66a; sha256 6ff7c5e91cba162655a979fa4cfb35adaadd4781ebe81829f5e32645dd9d9c59},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601701. Agents can read the archived copy with the MCP tool read_document.